Burden and trend of cardiovascular diseases in youths aged 0-19 years in China, Asia, and the world, with forecasts to 2036: a systematic analysis of the global burden of disease study 2021

中国、亚洲及全球0-19岁青少年心血管疾病负担及趋势,并预测至2036年:2021年全球疾病负担研究的系统分析

阅读:1

Abstract

OBJECTIVE: To combat the harmful impacts of cardiovascular diseases (CVDs) on public health, it is crucial to understand the epidemiologic features and disease burden. The study aims to identify the trends of CVDs burden in youths aged 0-19 years from 1990 to 2021 across the global, Asian, and Chinese contexts to inform more effective strategies and actions. METHODS: The data from the Global Burden of Diseases and Risk Factors Study (GBD) 2021 were analyzed, stratified by sex, age, the socio-demographic index (SDI) regions, disease subtypes, respectively. We also employed the Auto-Regressive Integrated Moving Average (ARIMA) to predict the future burden of CVDs up to 2036. RESULTS: In 2021, DALY rate of CVDs among children and adolescents were 303.140 (268.480-343.800) globally, 268.730 (242.730-298.350) in Asia and 148.800 (126.510-173.620) in China. It exhibited significant declined trends from 1990 to 2021, with average annual percentage changes (AAPCs) of -2.447, -2.665, and -4.379, respectively (all p < 0.001). Compared with males, females had relatively higher prevalence of CVDs globally (797.060 vs. 791.140 per 100,000). Rheumatic heart disease served as the most prominent subtype across the world. Non-optimal temperatures emerged as the primary risk factor for CVDs-related disability-adjusted life years (DALYs). The CVDs incidence rate is predicted to rise to 108.861 per 100,000 globally, while the rate in Asia remains steady and decreases in China in 2036. CONCLUSION: A substantial global burden of CVDs in youths aged 0-19 years remains the pressing public health issue in 2021. The burden of overall and type-specific CVDs varies by age, sex, SDI, regions and countries. Current and future challenges in CVDs prevention for youngsters implied by the epidemiologic features are highlighted in this study.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。